Posters

Minimally invasive supraciliary microstent for IOP control in combined POAG-cataract surgery: 2-year COMPASS RCT results

Poster Details

First Author: I. Ahmed CANADA

Co Author(s):    S. Vold   R. Brown   E. Craven   R. Stamper   C. Mattox   T. Ianchulev     

Abstract Details

Purpose:

To evaluate 2-year safety and efficacy of a supraciliary microstent (CyPass) for reducing IOP in POAG subjects having cataract surgery.

Setting:

Private eye clinic.

Methods:

POAG subjects qualified for cataract surgery (N=505) had unmedicated IOP measured prior to randomization to supraciliary stenting + phaco (Stent, n=131) or phaco (Control, n=374) groups (3:1 ratio). Efficacy and safety were evaluated for 24 postoperative months.

Results:

Stent and Control group respective baseline mean IOPs were 24.4±2.77 and 24.5±2.95 mmHg; 72.5 and 58.0% achieved >20% IOP reduction; 98.6% and 98.4% achieved 20/40 or better BCVA at 24 months. No serious AEs occurred.

Conclusions:

This first supraciliary microstenting RCT demonstrated satisfactory safety and significant IOP-reduction in POAG patients having cataract surgery.

Financial Disclosure:

One or more of the authors receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, One or more of the authors research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented